Cross-cultural Validation of a Screening Scale for the Misuse of Opioid Analgesics in Primary Care
NCT05431985 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160
Last updated 2022-06-24
Summary
Objective: Analgesic Opioids misuse among patients with chronic pain ranges from 0% to 50%. The general practitioner is the first prescriber of opioid analgesics Our objective was to validate in primary care the POMI (Prescription Opioid Misuse Index) to identify the misuse of AOs.
Study Setting: Patients with chronic pain, taking AOs for at least 3 months, and followed in general practice.
Study design: Psychometric study
Data Collection/Extraction methods: Eligible patients followed in general practice responded to the POMI: Test phase. They then responded after 2 weeks: the retest. The gold standard used was the DSM-V.
Conditions
- Chronic Pain
- Addiction Opiate
Sponsors & Collaborators
-
University Hospital, Clermont-Ferrand
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2019-03-01
- Completion
- 2019-07-01
Countries
- France
Study Locations
More Related Trials
-
A Strategy to Reduce Opioid Drug Prescribing by Clinicians
NCT03809507 ·Status: COMPLETED
-
Impact of a Pharmaceutical Interview at the Initiation of Opioid Treatment for Acute Non-cancer Pain
NCT07049796 ·Status: COMPLETED
-
Study of the Characteristics of Chronic Pain in Patients With Addiction
NCT05976178 ·Status: COMPLETED
-
Analgesic Self-medication for Acute Pain by Patients Awaiting a Consultation With a General Practitioner
NCT05412407 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Standard Opioid Prescription Versus Prescription Guided by Pharmacogenetic Analysis in Patients With Non-cancerous Chronic Pain.
NCT03498014 ·Status: WITHDRAWN ·Phase: NA
-
Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics
NCT03297853 ·Status: COMPLETED
-
Quantity of Opioids for Acute Pain and Limit Unused Medication
NCT03953534 ·Status: COMPLETED
-
Addressing the Risks of Long-Term Opioid Therapy in Chronic Noncancer Pain
NCT03161795 ·Status: COMPLETED
-
24-hour Oral Morphine Equivalent Based Opioid Prescribing After Surgery
NCT04043143 ·Status: COMPLETED ·Phase: NA
-
Variation in Opioid Prescribing and Use for Acute Pain in Diverse Populations
NCT04509115 ·Status: COMPLETED
-
Developing a Method to Objectively Measure Opioid Analgesia
NCT03605966 ·Status: ACTIVE_NOT_RECRUITING
-
The Experiences of People Prescribed Opioid Pain Medicines
NCT04888897 ·Status: COMPLETED
-
Evaluation of a Patient-Centred, Multidisciplinary Opioid Tapering Program for Individuals With Chronic Non-Cancer Pain on Long Term Opioid Therapy
NCT04902547 ·Status: COMPLETED ·Phase: NA
-
Opioid and Cannabinoid Pharmacokinetic Interactions
NCT00308555 ·Status: COMPLETED ·Phase: PHASE1
-
Usual Care Intervention Research Evaluating the Impact of a Personalized Pharmaceutical Plan on the Duration of Opioid Treatment in Non-cancerous Pain
NCT05196386 ·Status: COMPLETED ·Phase: NA
-
A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion
NCT02667158 ·Status: COMPLETED
-
Self Reported Deviations From Opioid Analgesic Prescription
NCT00907192 ·Status: COMPLETED
-
Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
NCT07102446 ·Status: RECRUITING ·Phase: NA
-
Using m-Health Tools to Reduce the Misuse of Opioid Pain Relievers
NCT03012087 ·Status: COMPLETED ·Phase: NA
-
Opiophobia in Adults With Advanced Cancer
NCT07093567 ·Status: ACTIVE_NOT_RECRUITING
-
Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use
NCT03248765 ·Status: TERMINATED
-
Chronic Pain OneSheet Clinical Trial
NCT04295135 ·Status: COMPLETED ·Phase: NA
-
I-COPE Study: Opioid Use and Pain Management in Older Adults
NCT04878562 ·Status: COMPLETED ·Phase: NA
-
Appropriate Opioid Quantities for Acute Pain - Pharmacist Study
NCT04484610 ·Status: COMPLETED ·Phase: PHASE4
-
A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV
NCT03657810 ·Status: COMPLETED ·Phase: PHASE3